Sign in

CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

SAB Biotherapeutics, Inc.

Sign in to watch
Ticker
SABS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
853899721
Phone
305-845-2813
Business address
777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
Former names
Big Cypress Acquisition Corp.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Material agreement
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. DEF 14A Proxy Proxy Statement
  5. 8-K Event Regulation FD disclosure
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. 4 Insider Changes in Ownership
  8. SCHEDULE 13D/A Stake Beneficial Ownership Report
  9. 8-K Event Material agreement · Other events
  10. 424B5 Offering Prospectus
  11. 424B5 Offering Prospectus
  12. SCHEDULE 13D/A Stake Beneficial Ownership Report
  13. 8-K Event Regulation FD disclosure · Other events
  14. 10-K Report Annual Report
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 2 of 22 · 433 filings